<DOC>
	<DOC>NCT03046238</DOC>
	<brief_summary>To Evaluate the effect of addition of Dexmedetomedine to ultrasound guided modified Pecs block on post operative analgesia &amp; stress response in patient undergoing modified radical mastectomy.</brief_summary>
	<brief_title>Efficacy and Safety of Dexmedetomidine Added to Modified Pectoral's Block in Breast Cancer Patients</brief_title>
	<detailed_description>60 patients (age ≥29 years) who scheduled for modified radical mastectomy surgery under general anesthesia. Group I (Bupivacaine group): patients underwent modified radical mastectomy were given preoperative ultrasound guided modified Pecs block with 30 mL of 0.25% bupivacaine divided into 10 ml injected between the pectoralis muscles on the interfasial plane, and 20 ml injected between the Pectoralis minor muscle and the serratus muscle.Group II (Bupivacaine + Dexmedetomidine group) : preoperative ultrasound guided modified Pecs block with 30 mL of 0.25% bupivacaine plus Dexmedetomidine (1 µg/kg) divided into 20 ml injected between the pectoralis muscles on the interfasial plane , and 10 ml injected between the Pectoralis minor muscle and the serratus muscle.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>ASA I II patients weight 50 100 kg) a history of bleeding diathesis, relevant drug allergy opioid dependence, sepsis, those with psychiatric illnesses</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>